19 Results

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. Berger
    Berger
  3. Chung
    Chung
  4. Durham
    Durham
  5. Park
    Park
  6. Tallman
    Tallman
  7. Chung
    Chung
  8. Kim
    Kim
  9. Rosen
    Rosen
  10. Ladanyi
    Ladanyi

Groups

  1. Center for Hematologic Malignancies (19)
  2. Department of Medicine (19)
  3. Executive Committee, Center for Hematologic Malignancies (19)
  4. GSK Faculty (19)
  5. Hematologic Malignancies, Division of (19)
  6. Human Oncology and Pathogenesis Program (19)
  7. Tow Center for Developmental Oncology (TCDO) (19)
  8. Sloan Kettering Institute Postdocs (17)
  9. Solid Tumor Oncology Division (13)
  10. Adult Leukemia (12)
  1. "Omar Abdel-Wahab"
  2. "Center for Hematologic Malignancies"
  3. "Michael Berger"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (8)
Groups
  1. Center for Hematologic Malignancies (19)
  2. Department of Medicine (19)
  3. Executive Committee, Center for Hematologic Malignancies (19)
  4. GSK Faculty (19)
  5. Hematologic Malignancies, Division of (19)
  6. Human Oncology and Pathogenesis Program (19)

More Groups

People
  1. Michael Berger (19)
  2. Omar Abdel-Wahab (19)
  3. Young Rock Chung (11)
  4. Benjamin Durham (9)
  5. Jae Park (9)
  6. Martin Tallman (9)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (4)

More Years

Publications
  1. Blood (7)
  2. Cancer Discovery (1)
  3. Cancer Research (1)
  4. Clinical Cancer Research (1)
  5. Haematologica (1)
  6. Leukemia Research (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Nature Publishing Group (4)
  3. American Association for Cancer Research (3)
  4. American Association for the Advancement of Science (1)
  5. Elsevier Ltd (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct-to-patient outreach
    Journal Article

    Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
    Journal Article

    Chowell, D.; Yoo, S. K.; Valero, C.; Pastore, A.; Krishna, C.; Lee, M.; Hoen, D.; Shi, H.; Kelly, D. W.; Patel, N.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Leveraging systematic functional analysis to benchmark an in silico framework distinguishes driver from passenger MEK mutants in cancer
    Journal Article

    Hanrahan, A. J.; Sylvester, B. E.; Chang, M. T.; Elzein, A.; Gao, J.; Han, W.; Liu, Y.; Xu, D.; Gao, S. P.; Gorelick, A. N.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Novel alterations in CSF1R, RET, and other diverse kinases in the histiocytoses with biochemical and structural insights into their mechanisms of activation
    Meeting Abstract

    Durham, B.; Lopez-Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S.; Pastore, A.; Mandelker, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Lopez Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S. X.; Pastore, A.; Yoshimi, A.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • KMT2C mediates the estrogen dependence of breast cancer through regulation of ERĪ± enhancer function
    Journal Article

    Gala, K.; Li, Q.; Sinha, A.; Razavi, P.; Dorso, M.; Sanchez-Vega, F.; Chung, Y. R.; Hendrickson, R.; Hsieh, J. J.; Berger, M.; more...
    Oncogene (2018)

    Fulltext@MSK | Save
  • Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
    Meeting Abstract

    Durham, B. H.; Getta, B.; Dietrich, S.; Taylor, J.; Won, H.; Bogenberger, J. M.; Scott, S. N.; Kim, E.; Chung, Y. R.; Chung, S. S.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Robust patient-derived xenografts (PDX) capture the disease fidelity of chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML)
    Meeting Abstract

    Balasis, M. E.; Yoshimi, A.; Vedder, A.; Feldman, K.; Ma, Y.; Zhang, H.; Lee, S. C. W.; Letson, C.; Niyongere, S.; Lu, S. X.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save